Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea

Phase 3 Unknown 300 enrolled Peking Union Medical College Hospital

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Compare the potential benefits of adjuvant toremifene with or without goserelin in premenopausal women with stage I-IIIA, hormonal receptor positive breast cancer accompanied with or without chemotherapy induced amenorrhoea.

Timeline

Start: 2014-05
Primary completion: 2024-05
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Goserelin	Other / unclassified	—	—
Subject	Toremifene	Small molecule	—	Oral

Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea

Summary

Timeline

Drugs

Indications